Genomic alterations in the epidermal growth factor receptor (EGFR) gene are found in approximately 15% of non-small-cell lung cancer (NSCLC) cases in the Caucasian and 50% in the Asian population [1,2,3]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.